Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSRT 2183 is an activator of sirtuin 1 (SIRT1; EC50 = 0.36 µM).1 However, it was found only to bind fluorophore-labeled SIRT1 and also inhibits 14 targets, including cannabinoid receptor 1 (CB1), adenosine receptor 3 (A3), and phosphodiesterase 5 (PDE5), in a panel of 100 receptors, enzymes, ion channels, and transporters at 10 µM.2 SRT 2183 (2 µM) inhibits RANKL-induced osteoclastogenesis in primary mouse bone marrow-derived macrophages (BMDMs).3 It inhibits apoptosis induced by hydrogen peroxide (H2O2) in primary mouse renal medullary interstitial cells when used at a concentration of 5 µM.4
WARNING This product is not for human or veterinary use.
1. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450(7170), 712-716 (2007).
2. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. The Journal of Biological Chemisty 285(11), 8340-8351 (2010).
3. The Sirt1 activators SRT2183 and SRT3025 Inhibit RANKL-
4. Sirt1 activation protects the mouse renal medulla from oxidative injury. J. Clin. Invest. 120(4), 1056-1068 (2010).